Healthcare -
Biotechnology - NASDAQ - GB
$ 0.2925
0.245 %
$ 75.4 M
Market Cap
-0.95
P/E
ADAP - OPERATING INCOME
Operating Income ADAP - Adaptimmune Therapeutics plc
-68.8 M
LAST VALUE
35.24%
2 YEAR CAGR
13.23%
5 YEAR CAGR
-16.95%
10 YEAR CAGR